grail

Grail Shares Surge as FDA Documents Signal Potential Path Toward Approval for Multi-Cancer Early Detection Test

Shares of Grail, the pioneer in multi-cancer early detection (MCED) technology, experienced a significant market rally on Monday, climbing 33%…